Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Join us for the first in a series — Connected to the Future Presidential Symposium Mary-Claire King, PhD, is a noted geneticist who discovered the BRCA1 gene and its connection to breast cancer risk. Among her many awards are the nation’s highest recognition for scientific achievement, the National Medal of Technology and Innovation, presented by President Obama in 2016. In 2014, she earned the prestigious Albert and Mary Lasker Foundation Award, often referred to as “America’s Nobels” for her work. GENETICS & PRECISION MEDICINE Friday, October 28, 2016 In addition to inherited breast and ovarian cancer, her research interests include the genetic bases of schizophrenia, genetic disorders in children, and human evolution. She pioneered the use of DNA sequencing for human rights investigations. Her current research employs the use of experimental and bioinformatics genomics tools to study complex genetic diseases in humans. Her research focuses on identifying and characterizing critical genes — and their interaction with environmental influences — that play a role in the development of conditions such as breast and ovarian cancer, schizophrenia, and hearing loss. University of Washington School of Medicine • American Cancer • Professor of Medicine Society Professor • Affiliate Member, • Professor of Genome Fred Hutchinson Cancer Sciences Research Center Saturday, October 29 1 p.m. KEYNOTE Mary-Claire King, PhD 8:30 - 9:00 a.m. Continental Breakfast 9:00 - 9:30 a.m.- Keynote: Scientists as Citizens of the World Mary-Claire King, PhD 9:30 - 10:30 a.m.Open discussion with panelists: Mark Polhemus, MD Director, Center for Global Health and Translational Science; Associate Professor of Medicine and Microbiology and Immunology Anna Stewart-Ibarra, PhD, MPH Assistant Professor of Medicine; Latin American Research Program Director, Center for Global Health and Translational Science 2-3 p.m. PRESENTATIONS 1-4 p.m. Reception to follow. Upstate Medical University welcomes special guest and keynote speaker Mary-Claire King, PhD Basic science foundations of personalized medicine Steven Glatt, PhD, Associate Professor of Psychiatry and Behavioral Health, Neuroscience and Physiology, and Neuroscience Graduate Program How science translates to medical applications Bernard Poiesz, MD, Professor of Medicine; Oncology, and Adult Hematology/Oncology; Medical Director, University Physicians Hematology/Oncology and Rheumatology Public health implications of personalized medicine Erasmus Schneider, PhD, Associate Director for Research and Technology; Director, Oncology Section, Clinical Laboratory Evaluation Program, Wadsworth Center, New York State Department of Health 3-4 p.m. OPEN DISCUSSION Moderated by Rinki Agarwal, MD, Assistant Professor, Obstetrics and Gynecology; Medical Director, Gynecology Oncology Program For more information, please contact Erin Peters, [email protected] e d u c a t i o n l h e a l t h c a r e l r e s e a r c h 16.3130816umusk All activities for the symposium will be held at the Upstate Biotech Accelerator, 841 East Fayette Street, Syracuse. FREE AND OPEN TO THE PUBLIC.